Generation of human-induced pluripotent stem cells from a patient with homozygous I1234V mutation of cystic fibrosis.
| Author | Emara, Mohamed M |
| Author | Thomas, Merlin |
| Author | Al Langawi, Mona |
| Author | Nomikos, Michail |
| Author | Mousa, Hanaa |
| Author | Aboukhalaf, Soha |
| Author | Abouzeid, Nadin H |
| Author | AlShanableh, Yasemin |
| Author | Al Thani, Maryam K |
| Author | Hussein, Yehia Y |
| Author | Swaidan, Nuha T |
| Author | Elsharabassi, Yasmin |
| Available date | 2024-09-29T07:19:07Z |
| Publication Date | 2024-04-08 |
| Publication Name | Qatar Medical Journal (QMJ) |
| Identifier | 10.5339/qmj.2024.qitc.4 |
| Citation | Emara, M. M., Thomas, M., Al Langawi, M., Nomikos, M., Mousa, H., Aboukhalaf, S., ... & Elsharabassi, Y. (2024). Generation of human-induced pluripotent stem cells from a patient with homozygous I1234V mutation of cystic fibrosis. Qatar Medical Journal, 2024(2). |
| ISSN | 0253-8253 |
| Abstract | Cystic fibrosis (CF) is an inherited autosomal recessive disorder. The most predominant mutation among Qatari patients with CF is the homozygous I1234V mutation, which is more prevalent in a Bedouin tribe.1 There are no reliable models of this mutation available to study the pathogenesis of CF; therefore, discovery of an effective treatment for the disease is ongoing. |
| Language | en |
| Publisher | Hamad bin Khalifa University Press |
| Subject | Cystic fibrosis Induced pluripotent stem cells homozygous I1234V mutation |
| Type | Article |
| Issue Number | 2 |
| Volume Number | 2024 |
| ESSN | 2227-0426 |
Files in this item
This item appears in the following Collection(s)
-
Medicine Research [1449 items ]